Minimal prostatic adenocarcinomas in the biopsy treated with radical prostatectomy;Adenocarcinomas mínimos de próstata en la biopsia sometidos a prostatectomía radical

Actas Urologicas Espanolas

Volumn 29, Issue 5, 2005, Pages 481-484

  Montesino Semper, M ^a   Jimenez Aristu J ^a   Fernandez Seara P ^a   Sarmiento Gomez C ^a   Ripa Saldias L ^a   Rivas Alonso, A ^a   Pinos Paul M ^a   De Pablo Cardenas A ^a   Villanueva Perez I ^a   Gonzalez De Garibay, A Santiago ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Adenocarcinoma of the prostate; Pathological study; Prostate

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 24344466313     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(05)73278-2     Document Type: Article

References (13)

1. Algaba F, Epstein JI, Aldape HC at al. Assessment of prostate carcinoma in core needle biopsy. Definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 1996;78:376-381.
2. Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Percent prostate tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002;167:516-520.
3. Villamon Fort R, Martínez Jabaloyas JM, Gil Salom M et al. El porcentaje de tumor en cilindros de biopsia prostática como factor pronóstico de enfermedad órganoconfinada en pacientes candidatos a prostatectomía radical. Actas Urol Esp 2001;25:493-498.
4. Allan RW, Sanderson H, Epstein JI. Correlation of minute (0,5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatetectomy specimen: role of prostate specific antigen density. J Urol 2003;170:370-372.
5. Rubin MA, Dunn R, Kambham N et al. Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?. Am J Surg Pathol 2000;24:1634-1640.
6. Leroy X, Aubert, Villers A et al. Minimal fous of adenocarcinoma on prostate biosy: clinicopathological correlations. J Clin Pathol 2003;56:230-232.
7. D'Amico AV, Wu Y, Chen MH et al. Pathologic findings and prostate specific antigen oucome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with Gleason score ≤ 7. Cancer, 2000;89:1810-1817.
8. Epstein JI, Chan DW, Sokol LJ, et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 1998;160:2407-2411.
9. Thorson P, Vollmer RT, Arcangeli C, et al. Minimal carcinoma en prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol 1998;11:543-551.
10. Bostwick DG, Grignon DJ, Hammond ME, et al. Pronostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:995-1000.
11. Montironi R, van der Kwast Th, Boccon-Gibod L, Bono A, Boccon-Gibod L. Handling and pathology reporting of radical prostatectomy specimens. Eur Urol 2003;44:626-636.
12. Montesino Semper M, Jiménez Aristu J, Repáraz Romero B, et al. Estudio de correlación entre las sumas de Gleason de las biopsias de próstata con adenocarcinoma y de las piezas de prostatectomia radical. Arch Esp Urol 2004;57:519-523.
13. Mohamad A, Ballentine CH. Update on watchful waiting for prostate cancer. Curr Opin Urol 2004;14:171-175.